Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network

BACKGROUND: Duchenne muscular dystrophy (DMD) is the most commonly inherited neuromuscular disease. Therapeutic agents for the treatment of rare disease, namely “orphan drugs”, have recently drawn the attention of researchers and pharmaceutical companies. To ensure the successful conduction of clini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Health Serv Res
Main Authors: Shimizu, Reiko, Ogata, Katsuhisa, Tamaura, Akemi, Kimura, En, Ohata, Maki, Takeshita, Eri, Nakamura, Harumasa, Takeda, Shin’ichi, Komaki, Hirofumi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Technical Advance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4939632/
https://ncbi.nlm.nih.gov/pubmed/27401940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-016-1477-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados